82 related articles for article (PubMed ID: 29768763)
1. The Learning-Adapting-Leveling model: from theory to hypothesis of steps for implementation of basic genome-based evidence in personalized medicine.
Lal JA; Vaidya A; Gutiérrez-Ibarluzea I; Dauben HP; Brand A
Per Med; 2013 Sep; 10(7):683-701. PubMed ID: 29768763
[TBL] [Abstract][Full Text] [Related]
2. The overarching framework of translation and integration into healthcare: a case for the LAL model.
Lal JA; Morré SA; Brand A
Per Med; 2014 Jan; 11(1):41-62. PubMed ID: 29751395
[TBL] [Abstract][Full Text] [Related]
3. Public health and valorization of genome-based technologies: a new model.
Lal JA; Schulte In den Bäumen T; Morré SA; Brand A
J Transl Med; 2011 Dec; 9():207. PubMed ID: 22142533
[TBL] [Abstract][Full Text] [Related]
4. Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
Leyens L; Horgan D; Lal JA; Steinhausen K; Satyamoorthy K; Brand A
Per Med; 2014 Sep; 11(7):641-649. PubMed ID: 29764055
[TBL] [Abstract][Full Text] [Related]
5. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
6. Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation.
Fackler JL; McGuire AL
Curr Pharmacogenomics Person Med; 2009 Jun; 7(2):125. PubMed ID: 20098629
[TBL] [Abstract][Full Text] [Related]
7. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
8. New challenges of public health: bringing the future of personalised healthcare into focus.
Ricciardi W; Boccia S
Eur J Public Health; 2017 Oct; 27(suppl_4):36-39. PubMed ID: 29028243
[TBL] [Abstract][Full Text] [Related]
9. Academic medical centers: ripe for rapid-learning personalized health care.
Ginsburg GS; Staples J; Abernethy AP
Sci Transl Med; 2011 Sep; 3(101):101cm27. PubMed ID: 21937754
[TBL] [Abstract][Full Text] [Related]
10. The contribution of health technology assessment, health needs assessment, and health impact assessment to the assessment and translation of technologies in the field of public health genomics.
Rosenkötter N; Vondeling H; Blancquaert I; Mekel OC; Kristensen FB; Brand A
Public Health Genomics; 2011; 14(1):43-52. PubMed ID: 20926845
[TBL] [Abstract][Full Text] [Related]
11. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
O'Donnell JC
Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
[TBL] [Abstract][Full Text] [Related]
12. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
13. The Translational Genomics Core at Partners Personalized Medicine: Facilitating the Transition of Research towards Personalized Medicine.
Blau A; Brown A; Mahanta L; Amr SS
J Pers Med; 2016 Feb; 6(1):. PubMed ID: 26927185
[TBL] [Abstract][Full Text] [Related]
14. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
15. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
Zhang A; Sun H; Wang P; Han Y; Wang X
Complement Ther Med; 2012; 20(1-2):93-9. PubMed ID: 22305254
[TBL] [Abstract][Full Text] [Related]
16. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
17. H2020 EU Research & Innovation Program Boost the Transfer of Technological Breakthroughs, Enable New Solutions for Personalised Health and Impact the Industry and Healthcare Systems.
Smit PH; Lymberis A
Stud Health Technol Inform; 2015; 211():3-17. PubMed ID: 25980846
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health.
Lal JA; Malogajski J; Verweij SP; de Boer P; Ambrosino E; Brand A; Ouburg S; Morré SA
Public Health Genomics; 2013; 16(1-2):50-61. PubMed ID: 23548718
[TBL] [Abstract][Full Text] [Related]
19. Bringing personalized medicine to the community through public engagement.
Etchegary H; Wilson B
Per Med; 2013 Sep; 10(7):647-659. PubMed ID: 29768762
[TBL] [Abstract][Full Text] [Related]
20. Public Health Genomics and personalized healthcare: a pipeline from cell to society.
Brand A
Drug Metabol Drug Interact; 2012; 27(3):121-3. PubMed ID: 23104820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
